Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Cash Flow-to-Debt Ratio
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥39.68 Million could theoretically repay 0% of its total liabilities (CN¥2.99 Billion) in one year. Explore 002653 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Also explore Xizang Haisco Pharmaceutical Group Co Lt balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year debt coverage analysis for Xizang Haisco Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 002653 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥786.00 Million | CN¥2.72 Billion | ▲ +69.6% |
| 2024 | 0.17x | CN¥442.05 Million | CN¥2.60 Billion | ▼ -6.0% |
| 2023 | 0.18x | CN¥449.58 Million | CN¥2.48 Billion | ▲ +458.3% |
| 2022 | 0.03x | CN¥94.55 Million | CN¥2.91 Billion | ▲ +88.9% |
| 2021 | 0.02x | CN¥35.80 Million | CN¥2.09 Billion | ▼ -82.1% |
| 2020 | 0.10x | CN¥206.21 Million | CN¥2.15 Billion | ▼ -66.6% |
| 2019 | 0.29x | CN¥764.26 Million | CN¥2.66 Billion | ▲ +44.2% |
| 2018 | 0.20x | CN¥472.61 Million | CN¥2.37 Billion | ▲ +8.8% |
| 2017 | 0.18x | CN¥391.81 Million | CN¥2.14 Billion | ▼ -32.9% |
| 2016 | 0.27x | CN¥409.20 Million | CN¥1.50 Billion | ▼ -34.0% |
| 2015 | 0.41x | CN¥443.03 Million | CN¥1.07 Billion | ▼ -36.8% |
| 2014 | 0.65x | CN¥502.57 Million | CN¥767.55 Million | ▼ -38.9% |
| 2013 | 1.07x | CN¥568.41 Million | CN¥530.24 Million | ▼ -45.0% |
| 2012 | 1.95x | CN¥464.75 Million | CN¥238.49 Million | ▼ -14.1% |
| 2011 | 2.27x | CN¥260.79 Million | CN¥114.95 Million | ▲ +9.2% |
| 2010 | 2.08x | CN¥367.38 Million | CN¥176.79 Million | ▲ +20.9% |
| 2009 | 1.72x | CN¥368.21 Million | CN¥214.22 Million | ▲ +152.5% |
| 2008 | 0.68x | CN¥94.45 Million | CN¥138.73 Million | — |